Skip to content

Clinical trials

Phase 3 Lymphoproliferative Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoproliferative Disorders Phase: Phase 3 Country / region: United States Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20051
20061
20083
20111
20121
20151
20171
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated3
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology3
Acerta Pharma BV1
Ariad Pharmaceuticals1
Case Comprehensive Cancer Center1
City of Hope Medical Center1
Jonsson Comprehensive Cancer Center1
Mayo Clinic1
Pierre Fabre Medicament1
Radiation Therapy Oncology Group1
Spectrum Pharmaceuticals, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoproliferative Disorders14
Lymphoma11
Lymphoma, Non-Hodgkin9
Leukemia8
Lymphoma, Large B-Cell, Diffuse8
Multiple Myeloma7
Neoplasms, Plasma Cell7
Hodgkin Disease6
Leukemia, Lymphocytic, Chronic, B-Cell6
Lymphoma, Follicular6

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.